NMR solution structure of PawS Derived Peptide 21 (PDP-21)
ID | Type | Value order | Atom ID 1 | Atom ID 2 |
---|---|---|---|---|
1 | disulfide | sing | 1:CYS4:SG | 1:CYS10:SG |
2 | covalent | sing | 1:GLY1:N | 1:ASP13:C |
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 83.8 % (124 of 148) | 96.2 % (75 of 78) | 63.8 % (37 of 58) | 100.0 % (12 of 12) |
Backbone | 82.4 % (61 of 74) | 96.0 % (24 of 25) | 68.4 % (26 of 38) | 100.0 % (11 of 11) |
Sidechain | 87.2 % (75 of 86) | 96.2 % (51 of 53) | 71.9 % (23 of 32) | 100.0 % (1 of 1) |
Aromatic | 44.4 % (8 of 18) | 88.9 % (8 of 9) | 0.0 % (0 of 9) | |
Methyl | 100.0 % (6 of 6) | 100.0 % (3 of 3) | 100.0 % (3 of 3) |
1. PawS Derived Peptide 21 (PDP-21)
GRPCYTLQSC FPDSolvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 283 K, pH 5.2
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | PawS Derived Peptide 21 (PDP-21) | natural abundance | 2 mg/mL | |
2 | H2O | natural abundance | 90 % | |
3 | D2O | natural abundance | 10 % |
Solvent system 100% D2O, Pressure 1 atm, Temperature 283 K, pH 5.2
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
4 | PawS Derived Peptide 21 (PDP-21) | natural abundance | 2 mg/mL | |
5 | D2O | natural abundance | 100 % |